These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 444264)

  • 21. Substrate specificity and inhibitor sensitivity of monoamine oxidase in rat kidney mitochondria.
    Lyles GA; Shaffer CJ
    Biochem Pharmacol; 1979 Apr; 28(7):1099-106. PubMed ID: 444267
    [No Abstract]   [Full Text] [Related]  

  • 22. The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by cimoxatone.
    Fowler CJ; Benedetti MS
    J Neurochem; 1983 Jun; 40(6):1534-41. PubMed ID: 6406646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum.
    Philips SR; Boulton AA
    J Neurochem; 1979 Jul; 33(1):159-67. PubMed ID: 572413
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of inhibitors on monoamine oxidase activity in mouse brain.
    Hall TR; Figueroa HR; Yurgens PB
    Pharmacol Res Commun; 1982 May; 14(5):443-53. PubMed ID: 6810387
    [No Abstract]   [Full Text] [Related]  

  • 25. The heterogeneity of monoamine oxidase in distinct populations of rat brain mitochondria.
    Owen F; Bourne R
    Biochem Pharmacol; 1977 Feb; 26(4):289-92. PubMed ID: 849318
    [No Abstract]   [Full Text] [Related]  

  • 26. Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits.
    Weinstock M; Gorodetsky E; Wang RH; Gross A; Weinreb O; Youdim MB
    Neuropharmacology; 2002 Nov; 43(6):999-1005. PubMed ID: 12423669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.
    Green AR; Mitchell BD; Tordoff AF; Youdim MB
    Br J Pharmacol; 1977 Jul; 60(3):343-9. PubMed ID: 890205
    [No Abstract]   [Full Text] [Related]  

  • 28. The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications.
    Fowler CJ; Oreland L; Callingham BA
    J Pharm Pharmacol; 1981 Jun; 33(6):341-7. PubMed ID: 6115003
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparison of cardiac and vascular clorgyline-resistant amine oxidase and monoamine oxidase. Inhibition by amphetamine, mexiletine and other drugs.
    Clarke DE; Lyles GA; Callingham BA
    Biochem Pharmacol; 1982 Jan; 31(1):27-35. PubMed ID: 7059347
    [No Abstract]   [Full Text] [Related]  

  • 30. Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145.
    Azam M; Jain S; Baquer NZ
    Biochem Pharmacol; 1990 Nov; 40(10):2215-8. PubMed ID: 2123104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular turnover numbers of different forms of mitochondrial monoamine oxidase in rat.
    Egashira T; Ekstedt B; Kinemuchi H; Wiberg A; Oreland L
    Med Biol; 1976 Aug; 54(4):272-7. PubMed ID: 957813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative study of catalytic properties of the liver monoamine oxidase from the squid Todarodes pacificus and the Wistar rat].
    Iagodina OV; Basova NE
    Zh Evol Biokhim Fiziol; 2001; 37(3):175-9. PubMed ID: 11605436
    [No Abstract]   [Full Text] [Related]  

  • 33. The nature of inhibition of cat brain mitochondrial monoamine oxidase by clorgyline.
    Youdim MB; Holman B
    J Neural Transm; 1975; 37(1):11-24. PubMed ID: 1159411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Conjugated dinitrocompound dianions as inhibitors of the oxidative deamination of monoamines].
    Gureeva ZP; Mostiaeva LV
    Biokhimiia; 1984 Nov; 49(11):1840-6. PubMed ID: 6549266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity of pig liver and pig brain mitochondrial monoamine oxidase.
    Ekstedt B; Oreland L
    Arch Int Pharmacodyn Ther; 1976 Jul; 222(1):157-65. PubMed ID: 984965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoamine oxidase substrates and substrate affinity.
    Domino EF
    Schizophr Bull; 1980; 6(2):292-7. PubMed ID: 6769148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current status of type A and type B monoamine oxidase (author's transl)].
    Suzuki O
    Seikagaku; 1980; 52(3):158-62. PubMed ID: 6774035
    [No Abstract]   [Full Text] [Related]  

  • 38. In vivo studies on the effect of monoamine oxidase inhibitors on dopamine and serotonin metabolism in rat brain areas.
    Clement HW; Grote C; Wesemann W
    J Neural Transm Suppl; 1990; 32():85-8. PubMed ID: 2128514
    [No Abstract]   [Full Text] [Related]  

  • 39. Serotonin oxidation by type B MAO of rat brain.
    Mitra C; Guha SR
    Biochem Pharmacol; 1980 May; 29(9):1213-6. PubMed ID: 6772194
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on the selective inhibition of membrane-bound rat liver monoamine oxidase.
    Mantle TJ; Wilson K; Long RF
    Biochem Pharmacol; 1975 Nov; 24(22):2031-8. PubMed ID: 1212252
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.